![Henry Rath](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henry Rath
Keine laufenden Positionen mehr
Karriereverlauf von Henry Rath
Ehemalige bekannte Positionen von Henry Rath
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | 26.04.2021 | 08.09.2023 |
AMGEN INC. | Corporate Officer/Principal | 01.05.2003 | 01.05.2012 |
SERES THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Oppenheimer & Co., Inc.
![]() Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
The Lek/Alcar Consulting Group, Inc.
![]() The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Baxter BioScience Corp.
![]() Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | - | - |
ASTRIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2012 | - |
Ausbildung von Henry Rath
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Harvard College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Corporate Officer/Principal | 7 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ASTRIA THERAPEUTICS, INC. | Health Technology |
AMGEN INC. | Health Technology |
SERES THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Baxter BioScience Corp.
![]() Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
The Lek/Alcar Consulting Group, Inc.
![]() The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Commercial Services |
Oppenheimer & Co., Inc.
![]() Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
Surface Oncology, Inc.
![]() Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Henry Rath
- Erfahrung